Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450034
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2007-03-19
Brief Title:
Optimization of Drug Treatment in Hospitalized Elderly OMAGE
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Impact of Optimization of Drug Treatment of Elderly Admitted in 4 Acute Geriatric Wards Randomized Trial
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OMAGE
Brief Summary:
A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population compared with usual care
Detailed Description:
Drug treatment in elderly is not yet optimal 20 to 30 of admissions of elderly aged over 80 are related to drug problems most of them being preventable To decrease drug related hospitalizations need iatrogenic prevention compliance improvement and underuse decrease A multifaceted intervention has been designed included three dimensions 1 drug optimization 2 patient andor caregiver education and 3 better coordination with home health professionals before discharge
A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population compared with usual care
A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population compared with usual care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None